Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. 台灣欒木萃取物降低動脈粥狀硬化與抑制腎臟癌細胞 786-O-SI3 侵襲和轉移之探討
 
  • Details
Options

台灣欒木萃取物降低動脈粥狀硬化與抑制腎臟癌細胞 786-O-SI3 侵襲和轉移之探討

Date Issued
2014
Author(s)
林敬尹
Chin-Yin Lin
Advisor
謝易修  
郭東益
Yih-Shou Hsieh  
Dong-Yih Kuo
URI
https://handle.ncl.edu.tw/11296/sr95wk
https://scholars.csmu.edu.tw/handle/123456789/36065
Abstract
台灣欒木是台灣特有的天然植物。過去研究指出,台灣欒木的萃取物在 DPPH 分析下具有清除人造自由基的能力。而在本實驗中,我們想要進一步以體外試驗去評估台灣欒木萃取物(KFEE) 的抑制低密度脂蛋白(LDL)的氧化能力,以及觀察台灣欒木萃取物是否會保護人類臍帶靜脈內皮細胞(HUVECs) 不受氧化型低密度脂蛋白(oxLDL) 的傷害。在初步的成分分析中,我們得知台灣欒木萃取物含有酚酸類的 Gallic acid 和 Caffeic acid 成分。而經過相對電泳泳動率(REM)、ApoB 蛋白斷裂分析、共軛雙烯以及 MDA 形成試驗後得知,台灣欒木萃取物確實具有保護 LDL 不被氧化的特性。同時,台灣欒木萃取物也可以保護 oxLDL 處理下的 HUVECs,抑制細胞的活性氧族群 (ROS) 生成與之後發生的粒線體膜電位低落和細胞核濃染等反應。在蛋白調控路徑上,cytochrome C 釋放與 caspase-3 活化的抑制同樣顯示了台灣欒木萃取物對 HUVECs 的保護機制。因此,實驗證實了台灣欒木萃取物也許具有減緩 LDL 氧化,保護 HUVECs 不被 oxLDL 所傷害的藥理特性。而在癌症治療的影響上,我們則發現,台灣欒木萃取物雖然對正常的腎臟細胞株 HK-2 和打入裸鼠皮下提升惡性程度的腎臟癌細胞株 786-O-SI3 都不具有細胞毒殺性,但卻能有效抑制 786-O-SI3 的侵襲及轉移特性。在使用最高濃度為 100 µg/mL 的加藥處理下,以免疫螢光染色則發現細胞 KFEE 能使 786-O-SI3 的細胞型態變成轉移性較差的圓形。並且以 Gelatin zymography、Casein zymography 以及 Western blot 等分析方法,觀察 KFEE 對 786-O-SI3 的影響後,結果也顯示 KFEE 會減少 matrix metallopeptidase 2 (MMP-2)、 p-FAK Try925、p-Paxillin Ser178、p-MEK1/2 和 p-Erk1/2,這些和癌轉移相關的蛋白表現量。同時,在小鼠尾靜脈注射癌細胞的動物模式下,也證實了 KFEE 具有減緩 786-O-SI3 轉移至肺部的情形。因此,在抑制腎臟癌細胞的侵襲上,KFEE 很可能具備潛在的治療效果。
Koelreuteria formosana ethanol extract (KFEE) is obtained from natural plants that are endemic in Taiwan. A study showed that KFEE has antioxidant activity in DPPH assay. This study evaluated the antioxidative activity of KFEE and the manner in which KFEE protects human umbilical vein endothelial cells (HUVECs) from oxidized LDL (oxLDL)-mediated dysfunction in vitro. We find KFEE has Gallic acid and Caffeic acid. And our results indicate that antioxidative activity of KFEE was defined by the relative electrophoretic mobility of oxLDL, fragmentation of ApoB, conjugated dienes production, and malondialdehyde (MDA) production through Cu2+-mediated oxidation of LDL. The KFEE also inhibited ROS generation and the subsequent mitochondrial membrane potential collapse, chromosome condensation, cytochrome C release, and caspase-3 activation induced by oxLDL in HUVECs. Our results indicate that KFEE may protect LDL oxidation and prevent oxLDL-induced cellular dysfunction of HUVECs. In the other hand, we exercised inhibition on the invasion and migration of 786-O-SI3 renal cell carcinoma (RCC) cells in the absence of cytotoxicity in this study. The cytotoxic effects of KFEE up to 100 µg/mL on 786-O-SI3 and normal renal cell line HK-2 were not observed. Then 786-O-SI3 cells were treated with KFEE at many concentrations, up to 100 µg/mL, for a defined period and then subjected to immunofluorescence assay, gelatin zymography, casein zymography, and Western blot to examine the impacts of KFEE. The results showed that KFEE decreased matrix metalloproteinases-2 (MMP-2), p-FAK Try925, p-paxillin Ser178, p-MEK1/2, p-Erk1/2. Then, we display that KFEE was found to be effective in reducing the lung metastases formation contrast to vehicle-treated control animals. In conclusion, KFEE inhibited the invasion of renal cancer cells and may have potential use as a chemopreventive agent against RCC metastasis.
Type
thesis
File(s)
No Thumbnail Available
Name

102CSMU5107030-001.zip

Size

11.56 MB

Format

Unknown

Checksum

(MD5):602d4b45f4e0a478deec49025a999bd2

Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback